Clinical trial
Early Conversion From Tacrolimus to Efalizumab Maintenance Therapy in Kidney…
NCT00472082 · Emory University, Other · Terminated
Key facts
| NCT number | NCT00472082 |
|---|---|
| Title | Early Conversion From Tacrolimus to Efalizumab Maintenance Therapy in Kidney Transplant Recipients |
| Official title | An Open Label, Single-Center Pilot Study of Early Conversion From Tacrolimus to Efalizumab Maintenance Therapy in Primary Renal Transplant Recipients |
| Lead sponsor | Emory University, Other |
| Collaborators | Genentech, Inc. Industry |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Transplantation, Chronic Kidney Failure |
| Intervention type | Drug |
| Interventions | efalizumab |
| Enrollment | 5 |
| Start date | May 1, 2007 |
| Primary completion | Apr 1, 2009 |
| Completion | Apr 1, 2009 |
| First posted | May 11, 2007 |
| Last update posted | Jan 27, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: